ImmunologybioRxivPreprint
Accessing the specific capacity of TIL-derived CD8 T-cells to suppress tumor recurrence in resectable HBV-HCC patients
Janine Kah, Lisa Staffeldt, Gregor Mattert…·Stefan Lüth
This study evaluates the effectiveness of TIL-derived CD8 T-cells in suppressing tumor recurrence in HBV-HCC patients through adoptive cell transfer and immune checkpoint inhibitor combination.
DOI 10.1101/2024.12.05.626571